US FDA Warning Letter Hits Strides On Data Integrity
Was blue binder of batch records in scrap yard a sign of deeper problems?
Even after the US FDA warns Strides on uncontrolled records destruction and poor OOS investigations at its Puducherry plant, firm remains confident in its US market growth projections.
